Inventor · disambiguated record
William Joseph Lennox
Also filed as: LENNOX WILLIAM · LENNOX WILLIAM J · LENNOX WILLIAM JOSEPH
16 granted patents·2 pending applications·225 citations·filing 2001–2015
94Inventor score
Top patents by PatentIndex Score
18 records- 0196US7767689B2Carboline derivatives useful in the treatment of cancerPTC THERAPEUTICS INC·Filed 2005·Granted Aug 3, 2010·40 cites·12 claims
- 0295US7601840B2Carboline derivatives useful in the inhibition of angiogenesisPTC THERAPEUTICS INC·Filed 2005·Granted Oct 13, 2009·39 cites·7 claims
- 0391US6767912B2Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2001·Granted Jul 27, 2004·34 cites·17 claims
- 0489US8372860B2Carboline derivatives useful in the inhibition of angiogenesisPTC THERAPEUTICS INC·Filed 2010·Granted Feb 12, 2013·12 cites·21 claims
- 0589US8367694B2Carboline derivatives useful in the inhibition of angiogenesisPTC THERAPEUTICS INC·Filed 2009·Granted Feb 5, 2013·12 cites·23 claims
- 0687US7585876B2Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2007·Granted Sep 8, 2009·8 cites·6 claims
- 0786US6770642B2Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2002·Granted Aug 3, 2004·23 cites·19 claims
- 0885US9271960B2Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational controlPTC THERAPEUTICS INC·Filed 2015·Granted Mar 1, 2016·4 cites·4 claims
- 0983US6903112B2Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2003·Granted Jun 7, 2005·14 cites·13 claims
- 1082US9351964B2Methods for treating cancer and non-neoplastic conditionsALMSTEAD NEIL·Filed 2010·Granted May 31, 2016·6 cites·6 claims
- 1181US7297705B2Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2004·Granted Nov 20, 2007·8 cites·6 claims
- 1278US7022701B2Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2004·Granted Apr 4, 2006·10 cites·9 claims
- 1378US6800640B2Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2002·Granted Oct 5, 2004·9 cites·14 claims
- 1477US8946444B2Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational controlLENNOX WILLIAM·Filed 2005·Granted Feb 3, 2015·4 cites·12 claims
- 1567US8735414B2Indole derivatives and methods for antiviral treatmentMACCOSS MALCOLM·Filed 2010·Granted May 27, 2014·2 cites·15 claims
- 1658US2011160190A1Carboline derivatives useful in the inhibition of angiogenesisPTC THERAPEUTICS INC·Filed 2011·Application pending·0 cites
- 1754US2005124603A1Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2005·Application pending·0 cites
- 1838US8940896B2Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesisMOON YOUNG-CHOON·Filed 2005·Granted Jan 27, 2015·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when William Joseph Lennox files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →